HK Stock Market Move | FANGZHOU Health (06086) rose more than 10% and reached a strategic cooperation with Bayer AG to jointly promote industry innovation and development.

FANGZHOU JIANKE (06086) rose more than 10%, and as of the time of writing, it has risen by 10.66% to 6.75 Hong Kong dollars with a trading volume of 4.5862 million Hong Kong dollars. On the news side, on December 16, FANGZHOU JIANKE and AstraZeneca China held a strategic cooperation signing ceremony in Shanghai, signing a strategic cooperation agreement to carry out in-depth cooperation on digital medical platform construction and Internet health management model upgrade. It is understood that this strategic cooperation will focus on deep cooperation in the treatment drugs of -thalassemia Liboloz and psoriasis treatment drug Sondido, exploring innovative digital marketing project management models. It is worth mentioning that Liboloz recently successfully renewed its listing on the national medical insurance catalog, and its new indications filed this year are expected to be approved in 2025; Sondido has also been officially included in the national medical insurance catalog this year.